143 related articles for article (PubMed ID: 12524154)
1. Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential.
Tan WF; Lin LP; Li MH; Zhang YX; Tong YG; Xiao D; Ding J
Eur J Pharmacol; 2003 Jan; 459(2-3):255-62. PubMed ID: 12524154
[TBL] [Abstract][Full Text] [Related]
2. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
[TBL] [Abstract][Full Text] [Related]
3. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
4. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
Yeh CH; Peng HC; Yang RS; Huang TF
Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
[TBL] [Abstract][Full Text] [Related]
5. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST
Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102
[TBL] [Abstract][Full Text] [Related]
7. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of quercetin on angiogenesis in larval zebrafish and human umbilical vein endothelial cells.
Zhao D; Qin C; Fan X; Li Y; Gu B
Eur J Pharmacol; 2014 Jan; 723():360-7. PubMed ID: 24239714
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy.
Pisanti S; Borselli C; Oliviero O; Laezza C; Gazzerro P; Bifulco M
J Cell Physiol; 2007 May; 211(2):495-503. PubMed ID: 17192847
[TBL] [Abstract][Full Text] [Related]
10. Baicalein and baicalin are potent inhibitors of angiogenesis: Inhibition of endothelial cell proliferation, migration and differentiation.
Liu JJ; Huang TS; Cheng WF; Lu FJ
Int J Cancer; 2003 Sep; 106(4):559-565. PubMed ID: 12845652
[TBL] [Abstract][Full Text] [Related]
11. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
Chuang CH; Liu CH; Lu TJ; Hu ML
Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
[TBL] [Abstract][Full Text] [Related]
12. Up-Regulated Expression of Matrix Metalloproteinases in Endothelial Cells Mediates Platelet Microvesicle-Induced Angiogenesis.
Sun C; Feng SB; Cao ZW; Bei JJ; Chen Q; Zhao WB; Xu XJ; Zhou Z; Yu ZP; Hu HY
Cell Physiol Biochem; 2017; 41(6):2319-2332. PubMed ID: 28463834
[TBL] [Abstract][Full Text] [Related]
13. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic effect of Nelumbo nucifera leaf extracts in human umbilical vein endothelial cells with antioxidant potential.
Lee JS; Shukla S; Kim JA; Kim M
PLoS One; 2015; 10(2):e0118552. PubMed ID: 25714482
[TBL] [Abstract][Full Text] [Related]
16. Vascular disrupting activity of combretastatin analogues.
Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol and quercetin inhibit angiogenesis in vitro.
Igura K; Ohta T; Kuroda Y; Kaji K
Cancer Lett; 2001 Sep; 171(1):11-6. PubMed ID: 11485823
[TBL] [Abstract][Full Text] [Related]
19. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
Luan X; Gao YG; Guan YY; Xu JR; Lu Q; Zhao M; Liu YR; Liu HJ; Fang C; Chen HZ
Toxicol Appl Pharmacol; 2014 Nov; 281(1):118-24. PubMed ID: 25250884
[TBL] [Abstract][Full Text] [Related]
20. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
